EGF and rheumatoid arthritis: Cleavage of its substrates, e.g., TNF-α, CXCL16 and EGF, in synovial tissue leads to increased pro-inflammatory activity, which coincides with the increased expression of ADAM10 observed in synovial tissue of RA patients [35, 36].